36 Grants (Page 1 of 2)
2021
BLR&D Research Career Scientist Award Application
Nakshatri, Harikrishna
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5IK6BX005244-02), 2020-04-01 -- 2025-03-31
 
Cancer Research Career Enhancement and Related Activities
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA082709-22-5158), $51,310USD, 1999-09-22 -- 2024-08-31
 
Mechanisms associated with systemic effects of cancer
Nakshatri, Harikrishna
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01BX002764-06), 2015-04-01 -- 2023-09-30
2020
BLR&D Research Career Scientist Award Application
Nakshatri, Harikrishna
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 1IK6BX005244-01), 2020-04-01 -- 2025-03-31
 
Cancer Research Career Enhancement and Related Activities
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA082709-21-5158), $51,310USD, 1999-09-22 -- 2024-08-31
 
Mechanisms associated with systemic effects of cancer
Nakshatri, Harikrishna
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 2I01BX002764-05A1), 04/01/2015 -- 09/30/2023
2019
Cancer Research Career Enhancement and Related Activities
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2P30CA082709-20-5158), $51,310USD, 2019
 
Impact of NF-kB methylation on chemoresistance and metastasis of breast cancer
LU, TAO and Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R03CA223906-02), $76,177USD, 01/01/2018 -- 12/31/2019
 
The Influence of Adipogenic Progenitors and Duffy-Null Phenotype on the Normal Breast and Breast Cancer Biology of Women of African Descent
Nakshatri, Harikrishna
U.S. Department Of Defense (Dod), Medical Research & Material Command/Congressionally Directed Medical Research Programs (ID: W81XWH2010577), $1,310,027USD, 2019-01-01 -- 2019-12-31
2018
Impact of NF-kB methylation on chemoresistance and metastasis of breast cancer
LU, TAO and Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R03CA223906-01), $78,534USD, 01/01/2018 -- 12/31/2019
 
Mechanisms associated with systemic effects of cancer
Nakshatri, Harikrishna
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01BX002764-04), 04/01/2015 -- 03/31/2019
2017
Estrogen-Estrogen Receptor axis in non-transformed breast epithelial cells: studies beyond MCF-7
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R03CA195250-02), $70,481USD, 12/04/2015 -- 11/30/2017
 
Mechanisms associated with systemic effects of cancer
Nakshatri, Harikrishna
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01BX002764-03), 04/01/2015 -- 03/31/2019
2016
Estrogen-Estrogen Receptor axis in non-transformed breast epithelial cells: studies beyond MCF-7
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R03CA195250-01A1), $78,000USD, 12/04/2015 -- 11/30/2017
 
Mechanisms associated with systemic effects of cancer
Nakshatri, Harikrishna
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01BX002764-02), 04/01/2015 -- 03/31/2019
2015
Mechanisms associated with systemic effects of cancer
Nakshatri, Harikrishna
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 1I01BX002764-01A1), 04/01/2015 -- 03/31/2019
2012
Anthrax Toxin Receptor as a marker and target of breast cancer stem cells
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R21CA152536-02), $167,475USD, 03/17/2011 -- 02/28/2014
 
Persistent microRNA changes in serum of cancer-free breast cancer patients
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R21CA159158-02), $167,475USD, 03/09/2011 -- 02/28/2014
2011
Anthrax Toxin Receptor as a marker and target of breast cancer stem cells
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R21CA152536-01A1), $200,970USD, 03/17/2011 -- 02/28/2013
 
Chemoprevention of tobacco carcinogen-induced bladder cancer
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R03CA143994-02), $74,690USD, 09/01/2010 -- 08/31/2013
 
Persistent microRNA changes in serum of cancer-free breast cancer patients
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R21CA159158-01), $200,970USD, 03/09/2011 -- 02/28/2013
2010
Chemoprevention of tobacco carcinogen-induced bladder cancer
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R03CA143994-01A1), $77,000USD, 09/01/2010 -- 08/31/2012
2009
Cancer Biology Training Program
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5T32CA111198-05), $321,542USD, 04/01/2005 -- 09/30/2011
 
Lung Cancer Chemoprevention through LC-1
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R03CA137796-02), $77,000USD, 09/15/2008 -- 02/28/2011
2008
Animal Model for Local Inflammation-Induced Breast Cancer
Nakshatri, Harikrishna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R03CA117486-02), $75,750USD, 09/24/2007 -- 08/31/2010